Skip to Main Content
Back to News

Lobbying Update: $30,000 of EQUIFAX lobbying was just disclosed

None

$30,000 of EQUIFAX lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Gathering information and insight on potential changes to requirements for use of E-Verify and other requirements for proof of work authorization"

You can find more data on corporate lobbying on Quiver Quantitative.

EFX Congressional Stock Trading

Members of Congress have traded $EFX stock 3 times in the past 6 months. Of those trades, 1 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $EFX stock by members of Congress over the last 6 months:

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

EFX Insider Trading Activity

EFX insiders have traded $EFX stock on the open market 11 times in the past 6 months. Of those trades, 0 have been purchases and 11 have been sales.

Here’s a breakdown of recent trading of $EFX stock by insiders over the last 6 months:

  • MARK W BEGOR (CEO) has made 0 purchases and 7 sales selling 44,321 shares for an estimated $11,284,981.
  • JAMIL FARSHCHI (EVP, CISO & CTO) sold 18,911 shares for an estimated $4,693,331
  • JOHN W JR GAMBLE (EVP, CFO & COO) has made 0 purchases and 2 sales selling 5,500 shares for an estimated $1,366,285.
  • LISA M NELSON (EVP, President International) sold 552 shares for an estimated $136,995

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

EFX Hedge Fund Activity

We have seen 344 institutional investors add shares of EFX stock to their portfolio, and 344 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

EFX Analyst Ratings

Wall Street analysts have issued reports on $EFX in the last several months. We have seen 7 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • Needham issued a "Buy" rating on 06/20/2025
  • Stifel issued a "Buy" rating on 06/18/2025
  • RBC Capital issued a "Outperform" rating on 06/18/2025
  • Morgan Stanley issued a "Overweight" rating on 06/10/2025
  • Oppenheimer issued a "Outperform" rating on 05/22/2025
  • Wells Fargo issued a "Overweight" rating on 05/21/2025
  • UBS issued a "Buy" rating on 02/07/2025

To track analyst ratings and price targets for EFX, check out Quiver Quantitative's $EFX forecast page.

EFX Price Targets

Multiple analysts have issued price targets for $EFX recently. We have seen 11 analysts offer price targets for $EFX in the last 6 months, with a median target of $295.0.

Here are some recent targets:

  • Ryan Griffin from BMO Capital set a target price of $280.0 on 07/10/2025
  • Jason Haas from Wells Fargo set a target price of $310.0 on 07/07/2025
  • Heather Balsky from B of A Securities set a target price of $285.0 on 06/23/2025
  • Mayank Tandon from Needham set a target price of $295.0 on 06/20/2025
  • Ashish Sabadra from RBC Capital set a target price of $300.0 on 06/18/2025
  • Shlomo Rosenbaum from Stifel set a target price of $295.0 on 06/18/2025
  • Toni Kaplan from Morgan Stanley set a target price of $305.0 on 06/10/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Add Quiver Quantitative to your Google News feed.Google News Logo

Suggested Articles